Therapeutic Approaches in Facioscapulohumeral Muscular Dystrophy.


Journal

Trends in molecular medicine
ISSN: 1471-499X
Titre abrégé: Trends Mol Med
Pays: England
ID NLM: 100966035

Informations de publication

Date de publication:
02 2021
Historique:
received: 14 07 2020
revised: 14 09 2020
accepted: 15 09 2020
pubmed: 24 10 2020
medline: 16 10 2021
entrez: 23 10 2020
Statut: ppublish

Résumé

Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common types of muscular dystrophy, affecting roughly one in 8000 individuals. The complex underlying genetics and poor mechanistic understanding has caused a bottleneck in therapeutic development. Until the discovery of DUX4 and its causal role in FSHD, most trials were untargeted with limited results. Emerging approaches can learn from these early trials to increase their chance of success. Here, we explore the evolution of FSHD clinical trials from nonspecific anabolic or anti-inflammatory/oxidant strategies to cutting-edge molecular therapies targeting DUX4, and we discuss the importance of clinical outcome measures. With combined advances across multiple facets of FSHD research, the field is now poised to accelerate the process of therapeutic discovery and testing.

Identifiants

pubmed: 33092966
pii: S1471-4914(20)30239-2
doi: 10.1016/j.molmed.2020.09.008
pmc: PMC8048701
mid: NIHMS1688257
pii:
doi:

Substances chimiques

Biomarkers 0
DUX4L1 protein, human 0
Homeodomain Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

123-137

Subventions

Organisme : NICHD NIH HHS
ID : P50 HD060848
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Références

Anesth Prog. 2013 Spring;60(1):25-31; quiz 32
pubmed: 23506281
Neurology. 2001 Oct 23;57(8):1434-40
pubmed: 11673585
Science. 2010 Sep 24;329(5999):1650-3
pubmed: 20724583
Rinsho Shinkeigaku. 2004 Oct;44(10):661-6
pubmed: 15568480
Gene. 1999 Aug 5;236(1):25-32
pubmed: 10433963
Muscle Nerve. 2016 Oct;54(4):696-701
pubmed: 26840230
Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16509-16515
pubmed: 32601200
Med Sci Sports Exerc. 1995 Nov;27(11):1471-6
pubmed: 8587482
Hum Mol Genet. 2016 Oct 15;25(20):4419-4431
pubmed: 28171552
Neurology. 1997 Jan;48(1):46-9
pubmed: 9008492
Neurology. 1998 May;50(5):1402-6
pubmed: 9595995
BMC Musculoskelet Disord. 2014 May 15;15:155
pubmed: 24886582
Mol Cell Biol. 2009 Feb;29(3):675-86
pubmed: 19047375
Nucleic Acids Res. 2016 Jun 20;44(11):5161-73
pubmed: 26951377
Neurology. 1999 Jan 1;52(1):151-6
pubmed: 9921863
Free Radic Biol Med. 2012 Sep 1;53(5):1068-79
pubmed: 22796148
Biol Open. 2018 Apr 26;7(4):
pubmed: 29618456
J Invest Dermatol. 2010 Sep;130(9):2269-76
pubmed: 20393480
Neurology. 2014 Sep 16;83(12):1056-9
pubmed: 25122204
FEBS Lett. 1998 Nov 20;439(3):287-90
pubmed: 9845339
Muscle Nerve. 2020 May;61(5):644-649
pubmed: 31884698
Curr Med Res Opin. 2009 Sep;25(9):2251-8
pubmed: 19622006
Hum Gene Ther. 2010 Jun;21(6):704-12
pubmed: 20095819
Trends Mol Med. 2015 May;21(5):295-306
pubmed: 25801126
PLoS Genet. 2017 Mar 8;13(3):e1006658
pubmed: 28273136
Eur J Paediatr Neurol. 2018 Sep;22(5):782-785
pubmed: 29753614
Sci Adv. 2019 Sep 11;5(9):eaaw7781
pubmed: 31535023
J Neuromuscul Dis. 2014;1(2):181-190
pubmed: 25705588
Hum Mol Genet. 2019 Jul 1;28(13):2224-2236
pubmed: 31067297
Neuromuscul Disord. 2006 Oct;16(9-10):553-8
pubmed: 16934468
JCI Insight. 2018 Nov 15;3(22):
pubmed: 30429376
Trends Pharmacol Sci. 2016 Apr;37(4):249-251
pubmed: 26917062
Dermatol Ther (Heidelb). 2018 Mar;8(1):5-16
pubmed: 29411317
Endocrinology. 2006 Jul;147(7):3586-97
pubmed: 16627583
Neuromuscul Disord. 2006 Nov;16(11):766-9
pubmed: 17005397
Annu Rev Cell Dev Biol. 2004;20:61-86
pubmed: 15473835
Clin Cancer Res. 2005 Nov 1;11(21):7607-13
pubmed: 16278378
J Pharmacol Exp Ther. 2019 Aug;370(2):219-230
pubmed: 31189728
Compr Physiol. 2017 Sep 12;7(4):1229-1279
pubmed: 28915324
Brain Res Bull. 1996;41(2):93-6
pubmed: 8879672
J Clin Endocrinol Metab. 2002 Jul;87(7):3274-8
pubmed: 12107236
Dev Cell. 2012 Jan 17;22(1):38-51
pubmed: 22209328
Cochrane Database Syst Rev. 2016 May 05;(5):CD003725
pubmed: 27149418
Genes (Basel). 2017 Mar 03;8(3):
pubmed: 28273791
BMC Med Genomics. 2011 Sep 27;4:67
pubmed: 21951698
Ann Neurol. 2011 Mar;69(3):540-52
pubmed: 21446026
Neurology. 2020 Jun 9;94(23):e2441-e2447
pubmed: 32467133
Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004760
pubmed: 17253521
N Engl J Med. 1996 Jul 4;335(1):1-7
pubmed: 8637535
Mol Ther. 2016 Aug;24(8):1405-11
pubmed: 27378237
J Neurol Sci. 1993 Jun;116(2):201-6
pubmed: 8393092
Neuromuscul Disord. 2017 Apr;27(4):358-362
pubmed: 28190647
Muscle Nerve. 2007 Oct;36(4):424-35
pubmed: 17541998
Mol Ther. 2012 Jul;20(7):1417-23
pubmed: 22508491
J R Soc Interface. 2015 Jan 6;12(102):20140797
pubmed: 25551153
Nat Genet. 2017 Jun;49(6):941-945
pubmed: 28459456
Neurology. 1997 Jan;48(1):38-46
pubmed: 9008491
Biochim Biophys Acta. 2014 Aug;1840(8):2452-9
pubmed: 24513306
Sci Transl Med. 2020 Mar 25;12(536):
pubmed: 32213627
Free Radic Biol Med. 2015 Apr;81:158-69
pubmed: 25246239
Acta Pharm Sin B. 2015 Sep;5(5):378-89
pubmed: 26579469
Sci Adv. 2019 Dec 11;5(12):eaaw7099
pubmed: 31844661
Clin Genet. 2020 Jun;97(6):799-814
pubmed: 32086799
J Cell Sci. 2016 Oct 15;129(20):3816-3831
pubmed: 27744317
Muscle Nerve. 2012 Dec;46(6):951-3
pubmed: 23225386
Skelet Muscle. 2017 Sep 4;7(1):16
pubmed: 28870238
Ann Neurol. 2016 Feb;79(2):257-71
pubmed: 26573217
Ann Neurol. 2008 May;63(5):561-71
pubmed: 18335515
Physiol Rev. 2008 Apr;88(2):729-67
pubmed: 18391178
Muscle Nerve. 2018 Jan 30;:
pubmed: 29381807
J Pharmacol Exp Ther. 2020 Sep;374(3):489-498
pubmed: 32576599
Neurotherapeutics. 2018 Oct;15(4):863-871
pubmed: 30361930
Hum Mol Genet. 2019 Feb 1;28(3):476-486
pubmed: 30312408
Neuropediatrics. 2015 Dec;46(6):371-6
pubmed: 26408798
Sensors (Basel). 2019 Jan 07;19(1):
pubmed: 30621103
Lancet Diabetes Endocrinol. 2015 Dec;3(12):948-57
pubmed: 26516121
Nat Cell Biol. 2007 Feb;9(2):210-7
pubmed: 17220880
Hum Mol Genet. 2020 Apr 15;29(6):1030-1043
pubmed: 32083293
J Physiol. 2004 Feb 15;555(Pt 1):175-88
pubmed: 14617677
Am J Hum Genet. 2016 May 5;98(5):1020-1029
pubmed: 27153398
Neurology. 1972 Apr;22(4):335-47
pubmed: 5062826
PLoS One. 2016 Jan 27;11(1):e0146893
pubmed: 26816005
Hum Mol Genet. 2013 Dec 1;22(23):4661-72
pubmed: 23821646
Ann Neurol. 1986 Nov;20(5):590-6
pubmed: 2431651
Neuromuscul Disord. 2004 Jan;14(1):33-8
pubmed: 14659410
Nat Med. 2020 Jul;26(7):1096-1101
pubmed: 32483358
Curr Opin Neurol. 2012 Oct;25(5):614-20
pubmed: 22892954
Nat Genet. 2017 Jun;49(6):935-940
pubmed: 28459454
Nat Genet. 2017 Jun;49(6):925-934
pubmed: 28459457
Sci Rep. 2019 Aug 6;9(1):11392
pubmed: 31388039
Front Neurol. 2019 Jul 23;10:755
pubmed: 31396142
Hum Mol Genet. 1994 Aug;3(8):1287-95
pubmed: 7987304
Neurology. 2000 May 9;54(9):1848-50
pubmed: 10802796
BMC Neurol. 2019 Sep 10;19(1):224
pubmed: 31506080
J Med Genet. 2012 Jan;49(1):41-6
pubmed: 21984748
J Int Soc Sports Nutr. 2017 Jun 13;14:18
pubmed: 28615996
Ann Neurol. 2004 Jun;55(6):845-50
pubmed: 15174019
J Neurol. 2018 Nov;265(11):2646-2655
pubmed: 30191320
PLoS One. 2016 Jan 11;11(1):e0146132
pubmed: 26751209
Neuromuscul Disord. 2016 Jul;26(7):405-13
pubmed: 27185459
Elife. 2015 Jan 07;4:
pubmed: 25564732
J Neurol. 2019 May;266(5):1127-1135
pubmed: 30778707
J Med Genet. 2019 Dec;56(12):828-837
pubmed: 31676591
Annu Rev Genomics Hum Genet. 2019 Aug 31;20:265-291
pubmed: 31018108
J Pediatr Neurol. 2018 Aug;16(4):222-231
pubmed: 30923442
Muscle Nerve. 2018 Aug;58(2):213-218
pubmed: 29543984
Muscle Nerve. 2018 Jun;57(6):921-926
pubmed: 29486514
Hum Mol Genet. 2016 Apr 15;25(8):1468-78
pubmed: 26787513
Curr Opin Support Palliat Care. 2013 Dec;7(4):352-60
pubmed: 24157714
Neurology. 2004 Aug 24;63(4):702-8
pubmed: 15326246
Lancet Neurol. 2014 Oct;13(10):987-96
pubmed: 25209738
Mol Ther. 2016 Mar;24(3):527-35
pubmed: 26527377
Nat Genet. 2012 Dec;44(12):1370-4
pubmed: 23143600
Ann Neurol. 1982 Oct;12(4):398-401
pubmed: 7149665
Mol Ther Methods Clin Dev. 2017 Dec 24;8:121-130
pubmed: 29387734
J Neurol Sci. 1973 May;19(1):105-8
pubmed: 4351739
Nat Genet. 1992 Sep;2(1):26-30
pubmed: 1363881
Muscle Nerve Suppl. 1995;2:S56-66
pubmed: 7739627
Mol Cell Biol. 2005 Dec;25(23):10220-34
pubmed: 16287840
Hum Mol Genet. 2015 Oct 15;24(20):5901-14
pubmed: 26246499
Rinsho Shinkeigaku. 2001 Oct;41(10):698-700
pubmed: 11993192
Cell. 2013 Sep 12;154(6):1380-9
pubmed: 23992846
Hum Mol Genet. 2019 Dec 1;28(23):3997-4011
pubmed: 31630170
Arch Phys Med Rehabil. 2009 Jul;90(7):1094-101
pubmed: 19577021
Hum Mol Genet. 2018 Dec 1;27(23):4024-4035
pubmed: 30107443
Magn Reson Imaging. 2010 Jun;28(5):698-707
pubmed: 20395096

Auteurs

Justin Cohen (J)

Department of Genetics, Yale School of Medicine, New Haven, CT, USA.

Alec DeSimone (A)

Department of Genetics, Yale School of Medicine, New Haven, CT, USA.

Monkol Lek (M)

Department of Genetics, Yale School of Medicine, New Haven, CT, USA.

Angela Lek (A)

Department of Genetics, Yale School of Medicine, New Haven, CT, USA. Electronic address: angela.lek@yale.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH